| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
White matter hyperintensities in Parkinson's disease. Clinical correlations.
|
Arch Neurol
|
1995
|
2.30
|
|
2
|
Psychiatric comorbidity in a population of Parkinson's disease patients.
|
Eur J Neurol
|
2004
|
1.80
|
|
3
|
IV amantadine improves chorea in Huntington's disease: an acute randomized, controlled study.
|
Neurology
|
2003
|
1.60
|
|
4
|
Oxidative damage and cytogenetic analysis in leukocytes of Parkinson's disease patients.
|
Neurology
|
2002
|
1.51
|
|
5
|
Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy.
|
Neurology
|
2008
|
1.50
|
|
6
|
White matter MRI hyperintensities in a hundred and twenty-nine consecutive migraine patients.
|
Cephalalgia
|
1994
|
1.49
|
|
7
|
Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society-European Section. Part I: early (uncomplicated) Parkinson's disease.
|
Eur J Neurol
|
2006
|
1.45
|
|
8
|
REM sleep behaviour disorder in Parkinson's disease: a questionnaire-based study.
|
Neurol Sci
|
2005
|
1.30
|
|
9
|
A study of five candidate genes in Parkinson's disease and related neurodegenerative disorders. European Study Group on Atypical Parkinsonism.
|
Neurology
|
1999
|
1.25
|
|
10
|
Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease.
|
Eur J Neurol
|
2013
|
1.24
|
|
11
|
A short scale for the assessment of motor impairments and disabilities in Parkinson's disease: the SPES/SCOPA.
|
J Neurol Neurosurg Psychiatry
|
2004
|
1.20
|
|
12
|
Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated) Parkinson's disease.
|
Eur J Neurol
|
2006
|
1.13
|
|
13
|
Psychiatric comorbidity and psychosocial stress in patients with tension-type headache from headache centers in Italy. The Italian Collaborative Group for the Study of Psychopathological Factors in Primary Headaches.
|
Cephalalgia
|
1999
|
1.13
|
|
14
|
Paroxetine in Parkinson's disease: effects on motor and depressive symptoms.
|
Neurology
|
2000
|
1.11
|
|
15
|
The diverse phenotype and genotype of pantothenate kinase-associated neurodegeneration.
|
Neurology
|
2005
|
1.07
|
|
16
|
Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease.
|
Mov Disord
|
2001
|
1.05
|
|
17
|
Intravenous amantadine improves levadopa-induced dyskinesias: an acute double-blind placebo-controlled study.
|
Mov Disord
|
2001
|
1.03
|
|
18
|
Spinocerebellar ataxia type 2 in southern Italy: a clinical and molecular study of 30 families.
|
J Neurol
|
1999
|
1.00
|
|
19
|
Assessment of midbrain atrophy in patients with progressive supranuclear palsy with routine magnetic resonance imaging.
|
Acta Neurol Scand
|
2007
|
0.98
|
|
20
|
Preferential occurrence of chromosome 21 malsegregation in peripheral blood lymphocytes of Alzheimer disease patients.
|
Cytogenet Cell Genet
|
1999
|
0.97
|
|
21
|
Cytogenetic analysis oxidative damage in lymphocytes of Parkinson's disease patients.
|
Neurol Sci
|
2001
|
0.97
|
|
22
|
SSRIs do not worsen Parkinson's disease: evidence from an open-label, prospective study.
|
Clin Neuropharmacol
|
2001
|
0.96
|
|
23
|
Epidemiology of multiple system atrophy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms.
|
Neurol Sci
|
2001
|
0.96
|
|
24
|
The relationship between cerebral vascular disease and parkinsonism: The VADO study.
|
Parkinsonism Relat Disord
|
2012
|
0.96
|
|
25
|
Clinical diagnosis of multiple system atrophy: level of agreement between Quinn's criteria and the consensus conference guidelines.
|
Acta Neurol Scand
|
2001
|
0.92
|
|
26
|
A case of sarcoidosis presenting as a non-specific intramedullary lesion.
|
Eur J Neurol
|
2007
|
0.92
|
|
27
|
Acute and chronic effects of clozapine in essential tremor.
|
Mov Disord
|
1999
|
0.92
|
|
28
|
Clinical outcome and magnetic resonance imaging of carbon monoxide intoxication. A long-term follow-up study.
|
Ital J Neurol Sci
|
1999
|
0.91
|
|
29
|
Improvement of motor function in early Parkinson disease by safinamide.
|
Neurology
|
2004
|
0.91
|
|
30
|
The genetics of ataxia: through the labyrinth of the Minotaur, looking for Ariadne's thread.
|
J Neurol
|
2014
|
0.91
|
|
31
|
Spontaneous and induced aneuploidy in peripheral blood lymphocytes of patients with Alzheimer's disease.
|
Hum Genet
|
1997
|
0.90
|
|
32
|
Paraneoplastic choreic syndrome during non-Hodgkin's lymphoma.
|
Mov Disord
|
2000
|
0.89
|
|
33
|
Differences in nigro-striatal impairment in clinical variants of early Parkinson's disease: evidence from a FP-CIT SPECT study.
|
Eur J Neurol
|
2009
|
0.89
|
|
34
|
Mitochondrial DNA rearrangements in young onset parkinsonism: two case reports.
|
J Neurol Neurosurg Psychiatry
|
2001
|
0.88
|
|
35
|
A whole-brain analysis in de novo Parkinson disease.
|
AJNR Am J Neuroradiol
|
2008
|
0.88
|
|
36
|
Environmental factors and Parkinson's disease: a case-control study in the Tuscany region of Italy.
|
Parkinsonism Relat Disord
|
2004
|
0.87
|
|
37
|
Presynaptic nigro-striatal function in a group of Alzheimer's disease patients with parkinsonism: evidence from a dopamine transporter imaging study.
|
J Neural Transm (Vienna)
|
2004
|
0.86
|
|
38
|
Gynecomastia in epileptics treated with phenobarbital, phenytoin and fluoresone: two case reports.
|
Ital J Neurol Sci
|
1983
|
0.86
|
|
39
|
Amantadine in Huntington's disease: open-label video-blinded study.
|
Neurol Sci
|
2002
|
0.86
|
|
40
|
Brain perfusion effects of cholinesterase inhibitors in Parkinson's disease with dementia.
|
J Neural Transm (Vienna)
|
2006
|
0.85
|
|
41
|
Myopathic involvement in two cases of Hallervorden-Spatz disease.
|
Brain Dev
|
1996
|
0.85
|
|
42
|
Headache, panic disorder and depression: comorbidity or a spectrum?
|
Neuropsychobiology
|
1995
|
0.84
|
|
43
|
Phenobarbital prophylaxis of post traumatic epilepsy.
|
Ital J Neurol Sci
|
1980
|
0.84
|
|
44
|
A crossover, controlled study comparing pergolide with bromocriptine as an adjunct to levodopa for the treatment of Parkinson's disease.
|
Neurology
|
1995
|
0.84
|
|
45
|
Evaluation of the Short Parkinson's Evaluation Scale: a new friendly scale for the evaluation of Parkinson's disease in clinical drug trials.
|
Clin Neuropharmacol
|
1997
|
0.84
|
|
46
|
Chromosome and oxidative damage biomarkers in lymphocytes of Parkinson's disease patients.
|
Int J Hyg Environ Health
|
2001
|
0.83
|
|
47
|
Disappearance of skin lipofuscin storage and marked clinical improvement in adult onset coeliac disease and severe vitamin E deficiency after chronic vitamin E megatherapy.
|
J Submicrosc Cytol Pathol
|
1996
|
0.83
|
|
48
|
Dopamine transporter imaging study in parkinsonism occurring in fragile X premutation carriers.
|
Neurology
|
2005
|
0.82
|
|
49
|
Adrenomyeloneurodystrophy with late cerebral involvement and evidence of a multiple autoimmune disorder.
|
J Inherit Metab Dis
|
1988
|
0.82
|
|
50
|
Pergolide compared with bromocriptine in Parkinson's disease: a multicenter, crossover, controlled study.
|
Mov Disord
|
1994
|
0.82
|
|
51
|
Smoking habits in multiple system atrophy and progressive supranuclear palsy. European Study Group on Atypical Parkinsonisms.
|
Neurology
|
2000
|
0.81
|
|
52
|
Proton magnetic resonance spectroscopy (1H-MRS) of motor cortex and basal ganglia in de novo Parkinson's disease patients.
|
Neurol Sci
|
2001
|
0.81
|
|
53
|
Neuroendocrine evaluation in catamenial epilepsy.
|
Funct Neurol
|
1987
|
0.81
|
|
54
|
Possible involvement of dopaminergic mechanisms in the antimigraine action of flunarizine.
|
Cephalalgia
|
1990
|
0.81
|
|
55
|
Prevalence of headache syndromes in panic disorder.
|
Int Clin Psychopharmacol
|
1999
|
0.81
|
|
56
|
Observational study of sleep-related disorders in Italian patients with Parkinson's disease: usefulness of the Italian version of Parkinson's disease sleep scale.
|
Neurol Sci
|
2011
|
0.81
|
|
57
|
Epidemiology of progressive supranuclear palsy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms.
|
Neurol Sci
|
2001
|
0.80
|
|
58
|
Prevalence of Parkinson's disease and other types of parkinsonism in the Aeolian Archipelago, Sicily.
|
Parkinsonism Relat Disord
|
2008
|
0.80
|
|
59
|
Low frequency stimulation of the nucleus tegmenti pedunculopontini increases cortical metabolism in parkinsonian patients.
|
Eur J Neurol
|
2010
|
0.80
|
|
60
|
Chromatic pattern-reversal electroretinograms (ChPERGs) are spared in multiple system atrophy compared with Parkinson's disease.
|
Neurol Sci
|
2006
|
0.80
|
|
61
|
The relation between EMG activity and kinematic parameters strongly supports a role of the action tremor in parkinsonian bradykinesia.
|
Mov Disord
|
2001
|
0.80
|
|
62
|
Species differences in the role of excitatory amino acids in experimental parkinsonism.
|
Neurosci Biobehav Rev
|
1997
|
0.79
|
|
63
|
Effects of carbamazepine on prolactin secretion in normal subjects and in epileptic subjects.
|
Clin Neuropharmacol
|
1985
|
0.79
|
|
64
|
Pharmacokinetics and pharmacodynamics of L-Dopa after acute and 6-week tolcapone administration in patients with Parkinson's disease.
|
Clin Neuropharmacol
|
1999
|
0.79
|
|
65
|
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice is enhanced by ethanol or acetaldehyde.
|
Life Sci
|
1987
|
0.79
|
|
66
|
Oxidative stress and APO E polymorphisms in Alzheimer's disease and in mild cognitive impairment.
|
Free Radic Res
|
2013
|
0.79
|
|
67
|
Different effects of levodopa and apomorphine on blink reflex recovery cycle in essential blepharospasm.
|
Eur Neurol
|
1997
|
0.79
|
|
68
|
Cytogenetic alterations in lymphocytes of Alzheimer's disease and Parkinson's disease patients.
|
Neurol Sci
|
2002
|
0.79
|
|
69
|
Spontaneous and induced chromosome damage in somatic cells of sporadic and familial Alzheimer's disease patients.
|
Mutagenesis
|
2001
|
0.79
|
|
70
|
Dopaminergic degeneration and perfusional impairment in Lewy body dementia and Alzheimer's disease.
|
Neurol Sci
|
2003
|
0.78
|
|
71
|
Mild affective symptoms in de novo Parkinson's disease patients: relationship with dopaminergic dysfunction.
|
Eur J Neurol
|
2012
|
0.78
|
|
72
|
Mesolimbic dopaminergic dysfunction in Parkinson's disease depression: evidence from a 123I-FP-CIT SPECT investigation.
|
J Neural Transm (Vienna)
|
2015
|
0.78
|
|
73
|
Effect of metadoxine on striatal dopamine levels in C57 black mice.
|
J Pharm Pharmacol
|
1993
|
0.78
|
|
74
|
'INDOTEST' in atypical hemicrania continua.
|
Cephalalgia
|
2008
|
0.78
|
|
75
|
Descriptive epidemiologic study of epilepsy syndromes in a district of northwest Tuscany, Italy.
|
Epilepsia
|
1991
|
0.78
|
|
76
|
Flunarizine in migraine prophylaxis: predictive factors for a positive response.
|
Cephalalgia
|
1998
|
0.78
|
|
77
|
Mexiletine in the treatment of torticollis and generalized dystonia.
|
Clin Neuropharmacol
|
2001
|
0.77
|
|
78
|
Properties of 3H-MPTP binding sites in human blood platelets.
|
Life Sci
|
1986
|
0.77
|
|
79
|
[Diurnal worsening in Parkinson patients treated with levodopa].
|
Riv Neurol
|
1992
|
0.77
|
|
80
|
Myopathic involvement and mitochondrial pathology in Kennedy disease and in other motor neuron diseases.
|
Curr Mol Med
|
2014
|
0.77
|
|
81
|
Valproate-withdrawal induced migraine.
|
Headache
|
1994
|
0.77
|
|
82
|
Transcranial Doppler ultrasound in migraine and tension-type headache after apomorphine administration: double-blind crossover versus placebo study.
|
Cephalalgia
|
1995
|
0.77
|
|
83
|
Validity and metric of MiniMental Parkinson and MiniMental State Examination in Parkinson's disease.
|
Neurol Sci
|
2013
|
0.77
|
|
84
|
Direct genetic evidence for involvement of tau in progressive supranuclear palsy. European Study Group on Atypical Parkinsonism Consortium.
|
Neurology
|
1998
|
0.76
|
|
85
|
Platelet 3H-imipramine binding and sulphotransferase activity in primary headache.
|
Cephalalgia
|
1994
|
0.76
|
|
86
|
Effect of naloxone on body temperature in postmenopausal women with Parkinson's disease.
|
Life Sci
|
1990
|
0.76
|
|
87
|
[Sleep disturbances in a case of Morvan's chorea (author's transl)].
|
Riv Patol Nerv Ment
|
1978
|
0.76
|
|
88
|
Excitatory amino acids and MPTP toxicity.
|
Adv Neurol
|
1996
|
0.76
|
|
89
|
Bedtime cabergoline in Parkinson's disease patients with excessive daytime sleepiness induced by dopamine agonists.
|
Neurol Sci
|
2003
|
0.76
|
|
90
|
Clinical and pharmacokinetic evaluation of L-dopa and cabergoline cotreatment in Parkinson's disease.
|
Clin Neuropharmacol
|
1997
|
0.76
|
|
91
|
The tau gene in progressive supranuclear palsy: exclusion of mutations in coding exons and exon 10 splice sites, and identification of a new intronic variant of the disease-associated H1 haplotype in Italian cases.
|
Neurosci Lett
|
1999
|
0.76
|
|
92
|
Identification and determination of 3,4-dihydroxyphenylacetaldehyde, the dopamine metabolite in in vivo dialysate from rat striatum.
|
J Neurochem
|
1996
|
0.76
|
|
93
|
Long-term follow-up after flunarizine or nimodipine discontinuation in migraine patients.
|
Cephalalgia
|
1996
|
0.75
|
|
94
|
Asymptomatic cardiac arrhythmias in periodic paralysis.
|
J Neurol Neurosurg Psychiatry
|
1988
|
0.75
|
|
95
|
Altered neuroendocrine regulation of luteinizing hormone secretion in postmenopausal women with Parkinson's disease.
|
Neuroendocrinology
|
1991
|
0.75
|
|
96
|
Dextromethorphan and parkinsonism.
|
Lancet
|
1992
|
0.75
|
|
97
|
Recommendations of the Sleep Study Group of the Italian Dementia Research Association (SINDem) on clinical assessment and management of sleep disorders in individuals with mild cognitive impairment and dementia: a clinical review.
|
Neurol Sci
|
2014
|
0.75
|
|
98
|
Psychometric properties of the Italian version of the Scales for Outcomes in Parkinson's disease- Cognition (SCOPA-Cog).
|
Funct Neurol
|
2013
|
0.75
|
|
99
|
No evidence of association between CAG expansions and essential tremor in a large cohort of Italian patients.
|
J Neural Transm (Vienna)
|
2001
|
0.75
|
|
100
|
[On the opportunity of treating with hyperbaric oxygenation (hyperbaric oxygen) for the prevention of post-interventional anoxic encephalopathy (delayed neurologic sequelae)].
|
Minerva Anestesiol
|
1991
|
0.75
|
|
101
|
Therapeutic efficacy of a partial dopamine agonist in drug-free parkinsonian patients.
|
J Neural Transm
|
1985
|
0.75
|
|
102
|
Common Genetic Conditions of Ischemic Stroke to Keep in Mind.
|
Curr Mol Med
|
2014
|
0.75
|
|
103
|
[Dexamethasone therapy in Huntington chorea: preliminary results].
|
Riv Neurol
|
1992
|
0.75
|
|
104
|
Prolactin secretion in epileptic subjects treated with phenobarbital: sex differences and circadian periodicity.
|
Epilepsia
|
1986
|
0.75
|
|
105
|
[The prevalence of active epilepsy in the Commune of Vecchiano, Tuscany].
|
Epidemiol Prev
|
1993
|
0.75
|
|
106
|
Circadian rhythm in gonadotropin secretion in children with constitutional stature delay.
|
Waking Sleeping
|
1979
|
0.75
|
|
107
|
Clinical usefulness of creatine kinase BB determination by a RIA method in serum of patients with cerebrovascular accidents.
|
J Nucl Med Allied Sci
|
1989
|
0.75
|
|
108
|
[Sleep in progressive supranuclear palsy].
|
Riv Patol Nerv Ment
|
1984
|
0.75
|
|
109
|
A case of pelvic floor myoclonic jerk syndrome.
|
Mov Disord
|
1996
|
0.75
|
|
110
|
[Study of somatotropin incretion during sleep in children with growth retardation].
|
Minerva Pediatr
|
1979
|
0.75
|
|
111
|
Paroxysmal exertion-induced dystonia secondary to Erdheim-Chester disease.
|
Clin Neurol Neurosurg
|
2012
|
0.75
|
|
112
|
Phenobarbital in the prophylaxis of late posttraumatic seizures.
|
Ital J Neurol Sci
|
1992
|
0.75
|
|
113
|
Electrophysiological evaluation of genito-sphincteric dysfunction in multiple system atrophy.
|
Int J Neurosci
|
2003
|
0.75
|
|
114
|
Serum levels of B subunit creatine kinase isoenzymes measured by a RIA method in patients with brain tumors and stroke. Preliminary results.
|
Acta Neurol (Napoli)
|
1987
|
0.75
|
|
115
|
Evaluation of a new radioimmunological assay for the determination of the B subunit of creatine kinase enzyme.
|
Boll Soc Ital Biol Sper
|
1984
|
0.75
|
|
116
|
Peripheral-type benzodiazepine receptors in human blood cells of patients affected by migraine without aura.
|
Neurochem Int
|
2000
|
0.75
|
|
117
|
Intra-arterial tissue plasminogen activator and abciximab in patients with acute basilar artery occlusion.
|
Neurol Sci
|
2013
|
0.75
|
|
118
|
[Amyotrophic lateral sclerosis with multiple myeloma].
|
Riv Neurol
|
1991
|
0.75
|
|
119
|
Pattern of plasma opioids in menstrually-related migraine and epilepsy.
|
Funct Neurol
|
1987
|
0.75
|
|
120
|
Contribution of cerebellum and brainstem in the control of eye movement: evidence from a functional study in a clinical model.
|
Acta Neurol Scand
|
2002
|
0.75
|
|
121
|
Cabergoline improves motor disability without modifying L-dopa plasma levels in fluctuating Parkinson's disease patients.
|
J Neural Transm Suppl
|
1995
|
0.75
|
|
122
|
Diagnosis of possible mild cognitive impairment in Parkinson's disease: validity of the SCOPA-Cog.
|
Parkinsonism Relat Disord
|
2013
|
0.75
|
|
123
|
[The apomorphine test for diagnosis of parkinsonian syndrome].
|
Riv Neurol
|
1991
|
0.75
|
|
124
|
Influence of physical exercise on β-amyloid, α-synuclein and tau accumulation: an in vitro model of oxidative stress in human red blood cells.
|
Arch Ital Biol
|
2017
|
0.75
|
|
125
|
Involvement of monoamine oxidase enzymes in the action of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine, a selective neurotoxin, in the squirrel monkey: binding and biochemical studies.
|
Brain Res
|
1986
|
0.75
|
|
126
|
'Airlplane headache' with aura.
|
Cephalalgia
|
2010
|
0.75
|
|
127
|
[EEG findings in hemophilia].
|
Riv Neurol
|
1977
|
0.75
|